MR

Mahesh Ramchandra Patil

Active Director Director DIN 07598670
DIN 07598670 First appointment Aug 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahesh Ramchandra Patil

Data last updated:

Mahesh Ramchandra Patil is a Director at Docgram Healthtech Private Limited (since 2025). The company operates in Healthcare.

DIN 07598670
Primary Designation Director
Industry Healthcare
First Appointment 13 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Docgram Healthtech Private Limited U62011PN2025PTC245060
Director13 Aug 20252025Active

Board colleagues of Mahesh Ramchandra Patil

NameDINCompanyDesignation
Atul Kharat Anandrao08332503Docgram Healthtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Docgram Healthtech Private Limited
Premium access

Shareholding and investment profile for Mahesh Ramchandra Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Ramchandra Patil

Mahesh Ramchandra Patil currently holds 1 directorship: Docgram Healthtech Private Limited (Director, since 13 Aug 2025).

Mahesh Ramchandra Patil was first appointed on 13 Aug 2025 as Director at Docgram Healthtech Private Limited.

The current boards of Mahesh Ramchandra Patil's companies include Atul Kharat Anandrao (Docgram Healthtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available